Navigation Links
Dendreon Submits Post-Approval Supplement to the PROVENGE Biologics License Application for New Jersey Manufacturing Facility
Date:11/10/2010

SEATTLE, Nov. 10, 2010 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) today announced that it has completed the submission of the post-approval supplement to the PROVENGE® (sipuleucel-T) Biologics License Application for the Morris Plains, New Jersey manufacturing facility. Dendreon is requesting licensure for an additional 36 workstations to manufacture PROVENGE. The standard U.S. Food and Drug Administration (FDA) review for a post-approval supplement to a Biologics License Application is typically four months.  

"The submission requesting licensure for additional capacity of the New Jersey manufacturing facility is an important milestone as we work to make PROVENGE more widely available to the many patients who may benefit from it," said Mitchell H. Gold, M.D., president and chief executive officer.

Dendreon's manufacturing facility in Morris Plains, New Jersey is currently operating at 25 percent capacity, with 12 workstations available to manufacture PROVENGE. With the FDA approval of the post-approval supplement to the Biologics License Application, the facility will have a total of 48 workstations. PROVENGE is the first in a new therapeutic class known as autologous cellular immunotherapies.

About Dendreon

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development, commercialization and manufacturing of novel therapeutics. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy (ACI) product candidates designed to stimulate an immune response in a variety of tumor types. Dendreon's first product, PROVENGE® (sipuleucel-T), was approved by the U.S. Food and Drug Administration (FDA) in April 2010. Dendreon is exploring the application of additional ACI product
'/>"/>

SOURCE Dendreon Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Dendreon to Host Conference Call on November 3rd to Announce Third Quarter Financial Results
2. Dendreon Announces Change in Board of Directors
3. Dendreon Announces Election of Dr. David C. Stump to Board of Directors
4. Dendreon Announces Presentation of PROVENGE Data at the American Society of Clinical Oncology Annual Meeting
5. Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering
6. Dendreon Announces Pricing of Common Stock Offering
7. Dendreon Appoints Hans Bishop as Chief Operating Officer
8. Dendreon Announces Proposed Public Offering of Common Stock
9. Dendreon Receives FDA Acknowledgement of Complete Response
10. Dendreon Reports Third Quarter 2009 Financial Results and Continuing Progress Toward PROVENGE Commercialization
11. Dendreon Completes Submission of Biologics License Application for PROVENGE
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... 3, 2015  Halozyme Therapeutics, Inc. (NASDAQ: HALO ... the second quarter 2015 on Monday, August 10, 2015 ... Torley , president and chief executive officer, will lead ... release financial results for the second quarter 2015. ... "Investors" section of Halozyme,s corporate website and a recording ...
(Date:8/3/2015)... , Aug. 3, 2015  Merck KGaA, Darmstadt, ... innovative and top-quality high-tech products in the healthcare, life ... the US-based company Nano-C, their development and launch of ... organic photovoltaics (OPV). Merck KGaA, Darmstadt, Germany ... the growing OPV sector. Novel derivatives: highly ...
(Date:8/3/2015)... 3, 2015 According to a ... Cell Culture: Asia to Witness ... the global 3D cell culture market was valued at US$ 586.1 ... a CAGR of 29.1% to account for US$ 2,717.6 ... TOC:  http://www.persistencemarketresearch.com/market-research/3d-cell-cultures-market.asp 3D cell culture refers ...
(Date:7/31/2015)... , July 31, 2015 China Cord ... China,s leading provider of cord blood ... cell storage services, today announced that the Company has ... U.S. Securities and Exchange Commission. The filed Form 20-F ... March 31, 2015. The Form 20-F can be accessed ...
Breaking Biology Technology:Halozyme to Host Second Quarter 2015 Financial Results Conference Call 2Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 2Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 3Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 4Global 3D Cell Culture Market Will Reach US$ 2,717.6 Million by 2020: Persistence Market Research 2Global 3D Cell Culture Market Will Reach US$ 2,717.6 Million by 2020: Persistence Market Research 3Global 3D Cell Culture Market Will Reach US$ 2,717.6 Million by 2020: Persistence Market Research 4China Cord Blood Corporation Files Its Annual Report on Form 20-F 2
... self-powered nano-device that can transmit data wirelessly over long ... Letters , they say it proves the feasibility of ... and stationary surveillance cameras and sensors, wearable personal electronics, ... energy collected from the environment. Zhong Lin ...
... in science is widely considered to be crucial for ... pharmacists to physician assistants and physical therapists, the future ... fields of healthcare and science. Yet, for the second ... for University of the Sciences ( http://www.usciences.edu ...
... LA JOLLA, Calif., June 15, 2011 Synthetic Genomics, ... solutions to a variety of global needs including clean ... that Joseph Mahler will join the company as Chief ... be responsible for leading and directing all financial aspect ...
Cached Biology Technology:Careers in Healthcare and Science? "Not Interested" Say Half of U.S. Teens 2Careers in Healthcare and Science? "Not Interested" Say Half of U.S. Teens 3Careers in Healthcare and Science? "Not Interested" Say Half of U.S. Teens 4Synthetic Genomics Inc. Appoints Joseph Mahler as Chief Financial Officer 2
(Date:7/31/2015)... Jul. 31, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market and creator ... filed provisional patent 62/198989 for ELECTRONIC CRYPTO-CURRENCY ... a method to advance crypto-currencies such as Bitcoin into ... common, uniform way to manage all payments.  ...
(Date:7/23/2015)... Aware, Inc. (NASDAQ: AWRE ), a leading supplier of ... second quarter ended June 30, 2015.  Revenue ... decrease of 33% compared to $6.8 million in the same ... 2015 was $0.3 million, or $0.01 per diluted share, which ... the same period a year ago.  Lower ...
(Date:7/20/2015)... DENVER , July 20, 2015  Acuity ... Mobility Report: The Convergence of Commerce and Privacy" ... billion mobile biometric apps will be downloaded to ... users. The mobile biometrics market is projected to ... app revenue during the seven-year forecast period.    ...
Breaking Biology News(10 mins):NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2
... and working in conjunction with Society in Science, ... new avenues in the relationship between science and society, ... authorship really matters. Based on a powerful authorship tracking ... its corresponding author. In this way readers can always ...
... zones are in the wrong place to protect vulnerable coral ... of scientists warned today., Now the team led jointly ... say that urgent action is needed to prevent the ... today in the journal PLoS ONE , is the ...
... today criticized the Bush administration,s Aug. 15 proposal ... impose regulatory changes eliminating the requirement for federal ... would allow federal agencies to decide for themselves ... plants. "The concept of independent scientific review ...
Cached Biology News:ETH Zurich-administered fund ends scientific anonymity 2No-take zones offer no boost for bleached reefs 2Ecological Society of America criticizes administration's overhaul of the Endangered Species Act 2
... protein into cells permits studies of protein-protein ... pathways, and transcription factor-mediated gene regulation. The ... of a specific protein in a mammalian ... into the cell. ProteoJuice Protein Transfection Reagent ...
... FACSVantageTM SE flow cytometry system is the ... For over 25 years, BD cell sorters ... found in leading university, pharmaceutical, and biotechnology ... meet the research demands of today, we ...
... SpliceArray Services is a ... industrial and academic researchers. ... Provider of Agilent, and we ... all Agilent catalogue arrays. ...
... stretching or compression of a single cell ... so you can precisely regulate the degree ... 64 unique strain parameters. ST-160 has a ... models are compatible with Nikon, Olympus, Leica, ...
Biology Products: